Resistance to antibacterial medications among community-acquired pathogens is a growing public health threat. [1][2][3][4][5] Key drivers are the volume and type of antibacterials used in ambulatory settings. [6][7][8] Antibacterials are often prescribed for acute nonspecific respiratory infections (ARIs), which they are unlikely to benefit. 9,10 Reducing such use can slow, or even reverse resistance rates.
British Journal of General Practice, October 2009 e321
Reduced antibiotic prescribing for acute respiratory infections in adults and children
Sharon B Meropol, Zhen Chen and Joshua P Metlay
SB Meropol, Z Chen and JP Metlay
ABSTRACT BackgroundRecent public health efforts, including in the UK and US, have targeted decreasing unnecessary antibiotic use. In the US, prescribing for acute non-specific respiratory infections (ARIs) has decreased, but broadspectrum antibacterial prescribing has soared.
AimTo assess recent trends in antibacterial prescribing for ARIs in the UK.
Design of studyRetrospective cohort.
SettingThe Health Improvement Network database.
MethodOutpatient ARI visits from 1 January 1990 to 31 December 2004 were selected. Outcomes were antibacterial and broad-spectrum antibacterial prescriptions per thousand person-years, and the probability of receiving an antibacterial and broadspectrum prescription conditional on an ARI visit.
ResultsFrom 1990 to 2004, antibacterial prescribing rates for ARIs decreased from 55.0 to 30.3 prescriptions/1000 person-years for adults and from 124.8 to 46.3 prescriptions/1000 person-years for children (P = 0.001). The probability of receiving an antibacterial prescription after an ARI visit decreased from 70.8% to 59.5% for adults and from 46.1% to 30.8% for children (P = 0.003 and 0.007, respectively). Antibacterial prescribing declined faster for younger than for older adults. Broad-spectrum antibacterial prescribing rates decreased from 3.8 to 2.9 prescriptions/1000 personyears for adults and from 5.2 to 2.2 prescriptions/1000 person years for children (P = 0.005 and 0.003, respectively). The probability of broad-spectrum prescribing did not demonstrate a significant linear trend for adults (P = 0.16), and decreased for children (P = 0.01).
ConclusionUK antibacterial prescribing for ARIs has declined, similar to US trends, but there was no concomitant increase in low broad-spectrum prescribing. The success of UK strategies for limiting antimicrobial use has implications for programmes in other countries.